Medical update: Hormone receptor-positive metastatic breast cancer

 

Hormone receptor-positive metastatic breast cancers test positive for estrogen (ER-positive) or progesterone (PR-positive) receptors, or both, and often respond to anti-estrogen therapies. This session details FDA approved and pipeline hormonal therapies, targeted therapies, and chemotherapy treatments used in this subtype of metastatic disease. Get informed about recently approved medicines and how they fit into ongoing treatment.